These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 24882898)

  • 21. CSF hypocretin-1 levels and clinical profiles in narcolepsy and idiopathic CNS hypersomnia in Norway.
    Heier MS; Evsiukova T; Vilming S; Gjerstad MD; Schrader H; Gautvik K
    Sleep; 2007 Aug; 30(8):969-73. PubMed ID: 17702265
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Neurophysiological examinations in narcolepsy].
    Wierzbicka A; Wichniak A; Czasak K; Musińska I; Jakubczyk T; Sek A; Jernajczyk W
    Przegl Lek; 2010; 67(9):726-8. PubMed ID: 21387813
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hypocretin/orexin and sleep: implications for the pathophysiology and diagnosis of narcolepsy.
    Overeem S; Scammell TE; Lammers GJ
    Curr Opin Neurol; 2002 Dec; 15(6):739-45. PubMed ID: 12447114
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Narcolepsy--new implications of molecular biology].
    Knudsen S; Jennum PJ
    Ugeskr Laeger; 2006 Oct; 168(43):3699-704. PubMed ID: 17069732
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Daytime sleepiness with and without cataplexy in Chinese-Taiwanese patients.
    Huang YS; Tafti M; Guilleminault C
    Sleep Med; 2006 Aug; 7(5):454-7. PubMed ID: 16815745
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hypocretin and human African trypanosomiasis.
    Dauvilliers Y; Bisser S; Chapotot F; Vatunga G; Cespuglio R; Josenando T; Buguet A
    Sleep; 2008 Mar; 31(3):348-54. PubMed ID: 18363311
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Insufficient non-REM sleep intensity in narcolepsy-cataplexy.
    Khatami R; Landolt HP; Achermann P; Rétey JV; Werth E; Mathis J; Bassetti CL
    Sleep; 2007 Aug; 30(8):980-9. PubMed ID: 17702267
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [A six year-old case of narcolepsy].
    Fujii Y; Fukumizu M; Sugai K; Kanbayashi T; Oyama K; Kamei A
    No To Hattatsu; 2003 Nov; 35(6):505-10. PubMed ID: 14631747
    [TBL] [Abstract][Full Text] [Related]  

  • 29. First rapid eye movement sleep periods and sleep-onset rapid eye movement periods in sleep-stage sequencing of hypersomnias.
    Drakatos P; Kosky CA; Higgins SE; Muza RT; Williams AJ; Leschziner GD
    Sleep Med; 2013 Sep; 14(9):897-901. PubMed ID: 23764105
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A study of the diagnostic utility of HLA typing, CSF hypocretin-1 measurements, and MSLT testing for the diagnosis of narcolepsy in 163 Korean patients with unexplained excessive daytime sleepiness.
    Hong SC; Lin L; Jeong JH; Shin YK; Han JH; Lee JH; Lee SP; Zhang J; Einen M; Mignot E
    Sleep; 2006 Nov; 29(11):1429-38. PubMed ID: 17162989
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Symptomatic narcolepsy, cataplexy and hypersomnia, and their implications in the hypothalamic hypocretin/orexin system.
    Nishino S; Kanbayashi T
    Sleep Med Rev; 2005 Aug; 9(4):269-310. PubMed ID: 16006155
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Narcolepsy and predictors of positive MSLTs in the Wisconsin Sleep Cohort.
    Goldbart A; Peppard P; Finn L; Ruoff CM; Barnet J; Young T; Mignot E
    Sleep; 2014 Jun; 37(6):1043-51. PubMed ID: 24882899
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CSF histamine contents in narcolepsy, idiopathic hypersomnia and obstructive sleep apnea syndrome.
    Kanbayashi T; Kodama T; Kondo H; Satoh S; Inoue Y; Chiba S; Shimizu T; Nishino S
    Sleep; 2009 Feb; 32(2):181-7. PubMed ID: 19238805
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Narcolepsy in the pediatric population.
    Viorritto EN; Kureshi SA; Owens JA
    Curr Neurol Neurosci Rep; 2012 Apr; 12(2):175-81. PubMed ID: 22213222
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hypocretin deficiency in narcolepsy with cataplexy is associated with a normal body core temperature modulation.
    Grimaldi D; Agati P; Pierangeli G; Franceschini C; Guaraldi P; Barletta G; Vandi S; Cevoli S; Plazzi G; Montagna P; Cortelli P
    Chronobiol Int; 2010 Sep; 27(8):1596-608. PubMed ID: 20854137
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Utility of measuring CSF hypocretin-1 level in patients with suspected narcolepsy.
    Gabryelska A; Szmyd B; Maschauer EL; Roguski A; Canham R; Morrison I; Białasiewicz P; Riha RL
    Sleep Med; 2020 Jul; 71():48-51. PubMed ID: 32492554
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical and polysomnographic course of childhood narcolepsy with cataplexy.
    Pizza F; Franceschini C; Peltola H; Vandi S; Finotti E; Ingravallo F; Nobili L; Bruni O; Lin L; Edwards MJ; Partinen M; Dauvilliers Y; Mignot E; Bhatia KP; Plazzi G
    Brain; 2013 Dec; 136(Pt 12):3787-95. PubMed ID: 24142146
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cataplexy with Normal Sleep Studies and Normal CSF Hypocretin: An Explanation?
    Drakatos P; Leschziner G
    J Clin Sleep Med; 2016 Mar; 12(3):449-50. PubMed ID: 26564387
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Progressive narcolepsy: how to deal with intermediate hypocretin-1 values?
    Ricordeau F; Bridoux A; Raverot V; Peter-Derex L
    J Clin Sleep Med; 2023 Jul; 19(7):1375-1378. PubMed ID: 37066739
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Narcolepsy with cataplexy].
    Dauvilliers Y; Arnulf I
    Rev Neurol (Paris); 2008; 164(8-9):634-45. PubMed ID: 18805301
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.